121 related items for PubMed ID: 38869717
1. Prediction Models for Intravenous Immunoglobulin Non-Responders of Kawasaki Disease Using Machine Learning.
Miyagi Y, Iwashima S.
Clin Drug Investig; 2024 Jun; 44(6):425-437. PubMed ID: 38869717
[Abstract] [Full Text] [Related]
2. Targeted Use of Prednisolone with Intravenous Immunoglobulin for Kawasaki Disease.
Sakai H, Iwashima S, Sano S, Akiyama N, Nagata E, Harazaki M, Fukuoka T.
Clin Drug Investig; 2021 Jan; 41(1):77-88. PubMed ID: 33341911
[Abstract] [Full Text] [Related]
3. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Dec; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
5. Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.
Kobayashi T, Inoue Y, Otani T, Morikawa A, Kobayashi T, Takeuchi K, Saji T, Sonobe T, Ogawa S, Miura M, Arakawa H.
Pediatr Infect Dis J; 2009 Jun; 28(6):498-502. PubMed ID: 19504733
[Abstract] [Full Text] [Related]
6. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T, Kato I, Shiohama T, Abe K, Anzai S, Takeda N, Yamaguchi KI, Kanazawa M, Kurosaki T.
Pediatr Int; 2011 Oct; 53(5):729-735. PubMed ID: 21342358
[Abstract] [Full Text] [Related]
7. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
Ha KS, Lee J, Lee KC.
Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
[Abstract] [Full Text] [Related]
8. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
[Abstract] [Full Text] [Related]
9. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
Pediatr Int; 2016 Mar; 58(3):180-184. PubMed ID: 26222760
[Abstract] [Full Text] [Related]
10. Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients.
Wang Y, Cao Y, Li Y, Zhu F, Yuan M, Xu J, Ma X, Li J.
Int Immunopharmacol; 2024 Jun 15; 134():112194. PubMed ID: 38703570
[Abstract] [Full Text] [Related]
11. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
J Pediatr; 2013 Aug 15; 163(2):521-6. PubMed ID: 23485027
[Abstract] [Full Text] [Related]
12. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 15; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
13. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
14. Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
Yoshikane Y, Okuma Y, Miyamoto T, Hashimoto J, Fukazawa R, Kato T, Takeda A, Suda K, Matsushita T, Hiroe M, Imanaka-Yoshida K.
Pediatr Rheumatol Online J; 2021 Jun 05; 19(1):82. PubMed ID: 34090475
[Abstract] [Full Text] [Related]
15. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Jun 05; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
16. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
Rheumatol Int; 2016 Jul 05; 36(7):905-10. PubMed ID: 27215220
[Abstract] [Full Text] [Related]
17. A simple scoring model based on machine learning predicts intravenous immunoglobulin resistance in Kawasaki disease.
Sunaga Y, Watanabe A, Katsumata N, Toda T, Yoshizawa M, Kono Y, Hasebe Y, Koizumi K, Hoshiai M, Kawakami E, Inukai T.
Clin Rheumatol; 2023 May 05; 42(5):1351-1361. PubMed ID: 36627530
[Abstract] [Full Text] [Related]
18. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
World J Pediatr; 2020 Dec 05; 16(6):607-613. PubMed ID: 32232677
[Abstract] [Full Text] [Related]
19. Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
Miyata K, Miura M, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H.
Circ Cardiovasc Qual Outcomes; 2021 Feb 05; 14(2):e007191. PubMed ID: 33541111
[Abstract] [Full Text] [Related]
20. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
Am J Ther; 2016 Feb 05; 23(6):e1293-e1299. PubMed ID: 25611359
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
